Menu
GeneBe

rs181665434

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000052.7(ATP7A):​c.3801+6T>C variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000776 in 1,206,679 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 325 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00050 ( 0 hom., 11 hem., cov: 22)
Exomes 𝑓: 0.00080 ( 0 hom. 314 hem. )

Consequence

ATP7A
NM_000052.7 splice_donor_region, intron

Scores

2
Splicing: ADA: 0.2049
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.967
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant X-78040739-T-C is Benign according to our data. Variant chrX-78040739-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 465120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATP7ANM_000052.7 linkuse as main transcriptc.3801+6T>C splice_donor_region_variant, intron_variant ENST00000341514.11
ATP7ANM_001282224.2 linkuse as main transcriptc.3567+6T>C splice_donor_region_variant, intron_variant
ATP7ANR_104109.2 linkuse as main transcriptn.974+6T>C splice_donor_region_variant, intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATP7AENST00000341514.11 linkuse as main transcriptc.3801+6T>C splice_donor_region_variant, intron_variant 1 NM_000052.7 P1Q04656-1

Frequencies

GnomAD3 genomes
AF:
0.000500
AC:
56
AN:
111969
Hom.:
0
Cov.:
22
AF XY:
0.000323
AC XY:
11
AN XY:
34105
show subpopulations
Gnomad AFR
AF:
0.0000974
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000951
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00111
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000920
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000502
AC:
92
AN:
183384
Hom.:
0
AF XY:
0.000663
AC XY:
45
AN XY:
67870
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00157
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.000709
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000804
AC:
880
AN:
1094656
Hom.:
0
Cov.:
30
AF XY:
0.000872
AC XY:
314
AN XY:
360210
show subpopulations
Gnomad4 AFR exome
AF:
0.000114
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000517
Gnomad4 EAS exome
AF:
0.0000331
Gnomad4 SAS exome
AF:
0.00202
Gnomad4 FIN exome
AF:
0.0000988
Gnomad4 NFE exome
AF:
0.000886
Gnomad4 OTH exome
AF:
0.000413
GnomAD4 genome
AF:
0.000500
AC:
56
AN:
112023
Hom.:
0
Cov.:
22
AF XY:
0.000322
AC XY:
11
AN XY:
34169
show subpopulations
Gnomad4 AFR
AF:
0.0000972
Gnomad4 AMR
AF:
0.0000950
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00111
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000920
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000800
Hom.:
5
Bravo
AF:
0.000484
EpiCase
AF:
0.000491
EpiControl
AF:
0.000711

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 28, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Ehlers-Danlos syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenDec 01, 2019- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxApr 13, 2020- -
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 27, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
15
DANN
Benign
0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.20
dbscSNV1_RF
Benign
0.22
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs181665434; hg19: chrX-77296237; API